miR-214, for instance, acts as a tumor suppressor by targeting the COP1-p53 pathway, thereby restoring the activity of the p53 tumor suppressor gene and promoting programmed cell death in angiosarcoma cells, restoring the activity of p53, a crucial gene that inhibits tumor growth. This evidence concerns the gene COP1 and angiosarcoma.